Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Melanoma: HELP
Articles by Valerie Florin
Based on 3 articles published since 2008
||||

Between 2008 and 2019, V. Florin wrote the following 3 articles about Melanoma.
 
+ Citations + Abstracts
1 Clinical Trial Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil. 2012

Florin, Valerie / Desmedt, Eve / Vercambre-Darras, Sophie / Mortier, Laurent. ·Department of Dermatology, Claude-Huriez Hospital, University Hospital of Lille, Lille, France. ·Invest New Drugs · Pubmed #21748297.

ABSTRACT: BACKGROUND: Despite multiple available options, the treatment of cutaneous melanoma metastases is often unsuccessful. Based on the hypothesis that imiquimod and 5-fluorouracil have synergistic antitumor properties, we used this topical combination to treat several patients. AIM: Our objective was to investigate the treatment combination in a small cohort of patients with surgically non-resectable melanoma metastases. METHODS: The lesions of 5 patients with multiple cutaneous metastases were treated topically, 5 days per week, with 5-fluorouracil in the morning and imiquimod at night. RESULTS: 45 lesions were treated. A clinical response was seen in 44 lesions, with a complete response in 19 lesions and a partial response in 25. Stable disease was confirmed in the 1 remaining lesion. No patients developed new lesions during treatment. However, one patient had a recurrence 6 months after treatment discontinuation, followed by a partial response when rechallenged. CONCLUSIONS: The imiquimod and 5-fluorouracil combination is effective. That patients did not develop new, distant lesions suggests the achievement of locoregional control, probably by the induction of antitumor immune response.

2 Article Oral metronomic cyclophosphamide in elderly with metastatic melanoma. 2010

Borne, Estelle / Desmedt, Eve / Duhamel, Alain / Mirabel, Xavier / Dziwniel, Véronique / Maire, Cyril / Florin, Valérie / Martinot, Véronique / Penel, Nicolas / Vercambre-Darras, Sophie / Mortier, Laurent. ·Clinique de Dermatologie, Centre Hospitalier Régional et Universitaire, Université Lille 2, Lille, France. ·Invest New Drugs · Pubmed #19669699.

ABSTRACT: INTRODUCTION: In Western countries, the number of frail elderly people with metastatic melanoma (MM) keeps increasing. Conventional chemotherapy frequently induces imbalance in frail physiological cases. We propose to treat these patients with oral metronomic cyclophosphamide. PATIENTS AND METHODS: This retrospective study analyses the data of patients with unresectable MM who received 50 to 100 mg of cyclophosphamide a day, 3 weeks out of 4. Main evaluation criterion was safety. Secondary evaluation criteria were objective response rate and overall survival. RESULTS: Thirteen patients were included (median age: 80, 5 AJCC stage III and 8 AJCC stage IV). Clinical and biological safety were good, leading to long home staying and rare treatment discontinuations. Main toxicity observed was lymphopenia; no opportunist infection occurred. The control rate was 46%: one partial response and five stable diseases (median: 10 months). Survival after beginning of treatment ranged from 4 to 37 months (median: 8 months). DISCUSSION: Literature about MM in frail elderly is limited. Still, specific treatment is necessary. Cyclophosphamide in metronomic schema was well tolerated. The response rate was difficult to assess (small population) but several patients presented with long lasting stabilisation. The mechanisms of action of this treatment are original, associating antiangiogenic action and immunomodulation. CONCLUSION: Cyclophosphamide in metronomic schema showed good safety results for this frail population. Oral treatment enabled patients to stay at home longer and limited hospitalisation time. A larger controlled study will be necessary to confirm these encouraging results in elderly with MM, a classical chemoresistant tumor.

3 Minor [Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil]. 2008

Florin, V / Vercambre-Darras, S / Piette, F / Mortier, L. · ·Ann Dermatol Venereol · Pubmed #18789300.

ABSTRACT: -- No abstract --